[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Synthomer Plc LSE:SYNT London Ordinary Share GB0009887422 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -14.80 -3.02% 475.40 475.20 476.20 482.80 475.00 479.40 776,999 16:29:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 1,644.2 20.3 0.7 679.1 2,222

Synthomer Share Discussion Threads

Showing 476 to 499 of 525 messages
Chat Pages: 21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
06/8/2021
08:49
Downgrade it is then.. BERENBERG CUTS SYNTHOMER TO 'HOLD' (BUY) - PRICE TARGET 550 (560) PENCE
philanderer
05/8/2021
23:26
Synthomer storms ahead Synthomer proves, if proof were needed, that even nitrile latex companies can have their day. HTTPS://www.investorschronicle.co.uk/news/2021/08/05/synthomer-storms-ahead/
philanderer
05/8/2021
20:54
I’ve had three COVID tests in the last eeek to travel. Every time a new pair of plastic disposable gloves. Use will continue for some time yet.
deanowls
05/8/2021
18:15
Canaccord put out a 'buy', tp 750p , on monday this week. ---------------- Canaccord ups price target on Synthomer Analysts at Canaccord Genuity raised their target price on chemicals outfit Synthomer from 700.0p to 750.0p on Monday, citing a fourth upgrade to full-year guidance. Synthomer announced a further update to its guidance for 2021 underlying earnings in July, EBITDA, now to "above £500.0m" from previous estimates of over £450.0m. The Canadian bank pointed out that the source of the further upgrade appeared to be broad-based. "Overall, we now expect net EPS to be up more than 150% this year on unit margins (€/ton) roughly doubling, with the overwhelming majority of that improvement coming from the nitrile business," said Canaccord. "Whilst normalisation is likely to come in the medium term, we continue to see super-normal profits in nitrile through 2022E, due both to the direct and ongoing impacts of the pandemic on PPE demand, but also the indirect increase in healthcare workers' (and others') demand for greater protection." As a result, Canaccord, which also stood by its 'buy' rating on the stock, upgraded 2022/23 EPS estimates by roughly 8% but also highlighted "increased optionality" at Synthomer, whether from the rapid debt reduction or opportunity for further expansion. [...]
philanderer
05/8/2021
13:45
bought more on the dips; very cheap at this price.
deadly
05/8/2021
11:03
...or maybe not ;-)
philanderer
05/8/2021
08:16
Looking good :-)
philanderer
05/8/2021
07:54
Outlook still reads well.
deanowls
05/8/2021
07:30
Excellent results: "Threefold increase in Group EBITDA to £322.7 million (2020: £100.2 million) ยท Strong growth delivered across all divisions, with all ahead of H1 2020 and H1 2019 Free Cash Flow up 59.3% to £89.5 million" Poor reaction by the market though. Is it because some of the gains are Covid-related?
deadly
03/8/2021
23:12
Interims duue thursday.
philanderer
20/7/2021
09:49
JEFFERIES RAISES SYNTHOMER PRICE TARGET TO 715 (650) PENCE - 'BUY'
philanderer
19/7/2021
08:54
Excellent update on a very sh1te market day.
philanderer
19/7/2021
06:55
Hound haven't closed their short. They've actually just increased to 0.7%. Ouch.
ppreston1
19/7/2021
06:49
Yes nice trading update ! Hound partners have now closed their short position. Onwards and upwards
peddlers
19/7/2021
06:41
Great trading update! Not sure about the wisdom of that short by Hound Partners.
ppreston1
14/7/2021
13:31
Noted that Hound Partners have initiated a short position against Synthomer. 0.63% as of 9th July.
ppreston1
14/7/2021
13:03
UBS RAISES SYNTHOMER PRICE TARGET TO 530 (520) PENCE - 'NEUTRAL'
philanderer
12/7/2021
17:16
p Thanks.
james dean
12/7/2021
15:43
Peel Hunt upgrades Synthomer Peel Hunt has upgraded chemicals business Synthomer (SYNT) as momentum builds in its end markets and M&A potential arises. Analyst Jolyon Wellington upgraded his recommendation from ‘add’ to ‘buy’ and increased the target price from 538p to 600p on the stock, which closed up 3.6%, or 18p, at 521p on Friday. ‘Synthomer’s end markets appear to be continuing strong momentum, and we believe upgrades to financial year 2022 [guidance] are possible at the forthcoming interims,’ he said. ‘With strong cashflow generation paying down debt, and new chief executive Michael Willome confirmed, M&A is back on the cards.’ He added the combination of Willome, an M&A specialist, and a ‘replenished balance sheet’ means the group could spend up to £1bn on acquisitions. HTTPS://citywire.co.uk/wealth-manager/news/share-tips-thg-st-modwen-bunzl-mj-gleeson-and-synthomer/a1529614#i=6
philanderer
09/7/2021
09:14
JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 650 (655) PENCE - 'BUY'
philanderer
09/7/2021
07:32
Richard Leonard mentions Synthoma (SYNT) in the latest PIWORLD Interview at 17m20s. Watch the video here: Https://www.piworld.co.uk/education-videos/a-piworld-interview-richard-leonard-what-hes-been-buying-july-2021/ Or listen to the podcast here: Https://piworld.podbean.com/e/a-piworld-interview-richard-leonard-what-he-s-been-buying-july-2021/
tomps2
06/7/2021
16:27
Around 3m shares bought today. Why isn't this going up?
ppreston1
30/6/2021
18:05
Hopefully just some end of quarter rebalancing.
ppreston1
30/6/2021
17:51
Looks like a big seller(s) unloading. 1 million+ shares traded today.
philanderer
Chat Pages: 21  20  19  18  17  16  15  14  13  12  11  10  Older
ADVFN Advertorial
Your Recent History
LSE
SYNT
Synthomer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211127 03:17:42